Guengerich et al., Oxidation of Dihydropyridine Calcium Channel Blockers and Analogues by Human Liver Cytochrome P-450 IIIA4, J. Med. Chem. 34: 1838-1844 (1991). |
Renaud et al., Expression of human liver cytochrome P450 IIIA4 in yeast. A functional model for the hepatic enzyme., Eur. J. Biochem. 194:L 889-896 (1990). |
Truan et al., Enhanced in vivo monooxygenase activities of mammalian P450s in engineered yeast cells producing high levels of NADPH-P450 reductase and human cytochrome b5, Gene 125: 49-55 (1993). |
Yamano et al., Human NADPH-P450 Oxidoreductase: Complementary DNA Cloning, Sequence and Vaccinia Virus-Mediated Expression and Localization of the CYPOR Gene to Chromosome 7, Molecular Pharmacology 35: 83-88 (1989). |
Miyata et al., Isolation and Characterization of Human Liver Cytochrome b5 cDNA, Pharmacological Research 21(5): 513-520 (1989). |
Urban et al., Xenobiotic metabolism in humanized yeast: engineered yeast cells producing human NADPH-cytochrome P-450 reductase, cytochrome b5, epoxide hydrolase and P-450s., Biochemical Society Transactions 21: 1028-1034 (1993). |
Urban et al. Biochimie. vol. 72, pp. 463-472, 1990. |
Peyronneau et al. Eur. J. Biochem. vol. 207, pp. 109-116, 1992. |
Eugster et al. Toxicology. vol. 82, pp. 61-73, 1993. |